281 related articles for article (PubMed ID: 23253955)
1. Accuracy of determining small renal mass management with risk stratified biopsies: confirmation by final pathology.
Halverson SJ; Kunju LP; Bhalla R; Gadzinski AJ; Alderman M; Miller DC; Montgomery JS; Weizer AZ; Wu A; Hafez KS; Wolf JS
J Urol; 2013 Feb; 189(2):441-6. PubMed ID: 23253955
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of renal mass biopsy risk stratification algorithm for robotic partial nephrectomy--could a biopsy have guided management?
Rahbar H; Bhayani S; Stifelman M; Kaouk J; Allaf M; Marshall S; Zargar H; Ball MW; Larson J; Rogers C
J Urol; 2014 Nov; 192(5):1337-42. PubMed ID: 24936720
[TBL] [Abstract][Full Text] [Related]
3. Age, Gender and R.E.N.A.L. Nephrometry Score do not Improve the Accuracy of a Risk Stratification Algorithm Based on Biopsy and Mass Size for Assigning Surveillance versus Treatment of Renal Tumors.
Osawa T; Hafez KS; Miller DC; Montgomery JS; Morgan TM; Palapattu GS; Weizer AZ; Caoili EM; Ellis JH; Kunju LP; Wolf JS
J Urol; 2016 Mar; 195(3):574-80. PubMed ID: 26523883
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous biopsy of renal cell carcinoma underestimates nuclear grade.
Blumenfeld AJ; Guru K; Fuchs GJ; Kim HL
Urology; 2010 Sep; 76(3):610-3. PubMed ID: 20163843
[TBL] [Abstract][Full Text] [Related]
5. Can renal biopsy accurately predict histological subtype and Fuhrman grade of renal cell carcinoma?
Millet I; Curros F; Serre I; Taourel P; Thuret R
J Urol; 2012 Nov; 188(5):1690-4. PubMed ID: 22998910
[TBL] [Abstract][Full Text] [Related]
6. The value of preoperative needle core biopsy for diagnosing benign lesions among small, incidentally detected renal masses.
Shannon BA; Cohen RJ; de Bruto H; Davies RJ
J Urol; 2008 Oct; 180(4):1257-61; discussion 1261. PubMed ID: 18707712
[TBL] [Abstract][Full Text] [Related]
7. Limitations of preoperative biopsy in patients with metastatic renal cell carcinoma: comparison to surgical pathology in 405 cases.
Abel EJ; Carrasco A; Culp SH; Matin SF; Tamboli P; Tannir NM; Wood CG
BJU Int; 2012 Dec; 110(11):1742-6. PubMed ID: 22503066
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous core biopsy of small renal mass lesions: a diagnostic tool to better stratify patients for surgical intervention.
Menogue SR; O'Brien BA; Brown AL; Cohen RJ
BJU Int; 2013 Apr; 111(4 Pt B):E146-51. PubMed ID: 22805186
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis of renal tumors on needle biopsy specimens by histological and molecular analysis.
Barocas DA; Rohan SM; Kao J; Gurevich RD; Del Pizzo JJ; Vaughan ED; Akhtar M; Chen YT; Scherr DS
J Urol; 2006 Nov; 176(5):1957-62. PubMed ID: 17070218
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of small renal mass needle core biopsy, nondiagnostic percutaneous biopsy, and the role of repeat biopsy.
Leveridge MJ; Finelli A; Kachura JR; Evans A; Chung H; Shiff DA; Fernandes K; Jewett MA
Eur Urol; 2011 Sep; 60(3):578-84. PubMed ID: 21704449
[TBL] [Abstract][Full Text] [Related]
11. Comparison of accuracy of 14-, 18- and 20-G needles in ex-vivo renal mass biopsy: a prospective, blinded study.
Breda A; Treat EG; Haft-Candell L; Leppert JT; Harper JD; Said J; Raman S; Smith RB; Belldegrun AS; Schulam PG
BJU Int; 2010 Apr; 105(7):940-5. PubMed ID: 19888984
[TBL] [Abstract][Full Text] [Related]
12. [Diagnostic value of percutaneous biopsy of the renal masses. 73 cases].
Daniel L; Barriol D; Lechevallier E; André M; De Fromont M; Charafe E; Coulange C; Pellissier J
Ann Pathol; 2000 Mar; 20(2):119-23. PubMed ID: 10740006
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous biopsy of renal masses: sensitivity and negative predictive value stratified by clinical setting and size of masses.
Rybicki FJ; Shu KM; Cibas ES; Fielding JR; vanSonnenberg E; Silverman SG
AJR Am J Roentgenol; 2003 May; 180(5):1281-7. PubMed ID: 12704038
[TBL] [Abstract][Full Text] [Related]
14. Renal cell carcinoma sub-typing by histopathology and fluorescence in situ hybridization on a needle-biopsy specimen.
Barocas DA; Mathew S; DelPizzo JJ; Vaughan ED; Sosa RE; Fine RG; Akhtar M; Scherr DS
BJU Int; 2007 Feb; 99(2):290-5. PubMed ID: 17092279
[TBL] [Abstract][Full Text] [Related]
15. Under-grading of <4 cm renal masses on renal biopsy.
Harris CR; Whitson JM; Meng MV
BJU Int; 2012 Sep; 110(6):794-7. PubMed ID: 22404857
[TBL] [Abstract][Full Text] [Related]
16. External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology.
Zigeuner R; Hutterer G; Chromecki T; Imamovic A; Kampel-Kettner K; Rehak P; Langner C; Pummer K
Eur Urol; 2010 Jan; 57(1):102-9. PubMed ID: 19062157
[TBL] [Abstract][Full Text] [Related]
17. Active surveillance of small renal masses: progression patterns of early stage kidney cancer.
Jewett MA; Mattar K; Basiuk J; Morash CG; Pautler SE; Siemens DR; Tanguay S; Rendon RA; Gleave ME; Drachenberg DE; Chow R; Chung H; Chin JL; Fleshner NE; Evans AJ; Gallie BL; Haider MA; Kachura JR; Kurban G; Fernandes K; Finelli A
Eur Urol; 2011 Jul; 60(1):39-44. PubMed ID: 21477920
[TBL] [Abstract][Full Text] [Related]
18. Accuracy of percutaneous core biopsy in management of small renal masses.
Wang R; Wolf JS; Wood DP; Higgins EJ; Hafez KS
Urology; 2009 Mar; 73(3):586-90; discussion 590-1. PubMed ID: 19118884
[TBL] [Abstract][Full Text] [Related]
19. Understanding the role of percutaneous biopsy in the management of patients with a small renal mass.
Tan HJ; Jacobs BL; Hafez KS; Montgomery JS; Weizer AZ; Wood DP; Miller DC; Wolf JS
Urology; 2012 Feb; 79(2):372-7. PubMed ID: 22310755
[TBL] [Abstract][Full Text] [Related]
20. Can renal mass biopsy assessment of tumor grade be safely substituted for by a predictive model?
Jeldres C; Sun M; Liberman D; Lughezzani G; de la Taille A; Tostain J; Valeri A; Cindolo L; Ficarra V; Artibani W; Zigeuner R; Mejean A; Descotes JL; Lechevallier E; Mulders PF; Perrotte P; Patard JJ; Karakiewicz PI
J Urol; 2009 Dec; 182(6):2585-9. PubMed ID: 19836799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
